RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Free Cash Flow of -$109213.0 for Q1 2026, up 14.82% sequentially from -$128219.0 in Q4 2025, and up 41.67% YoY from -$77091.6 in Q1 2025.
RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Free Cash Flow for 7 years, with the latest figure at -$109213.0 in Q1 2026.
- Quarterly Free Cash Flow rose 41.67% year-over-year to -$109213.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$480341.0 (up 37.24% YoY) and the FY2025 annual result came in at -$558350.0, up 24.74% from the prior year.
- Free Cash Flow climbed to -$109213.0 in Q1 2026 per RTGN's latest filing, from -$128219.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at $39749.0 in Q3 2023 and troughed at -$290025.0 in Q4 2023.
- A 5-year average of -$121202.8 and a median of -$123810.0 in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 167.42% in 2023, down 1100.41% in 2023.
- Over 5 years, Free Cash Flow stood at -$33225.0 in 2022, then plunged by 772.91% to -$290025.0 in 2023, then soared by 35.73% to -$186390.0 in 2024, then surged by 31.21% to -$128219.0 in 2025, then increased by 14.82% to -$109213.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$109213.0, -$128219.0, and -$103837.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -109,213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,213.00 |
| Mar 31, 2026 | -109,213.00 |
| Dec 31, 2025 | -128,219.00 |
| Dec 31, 2025 | -128,219.00 |
| Sep 30, 2025 | -103,837.00 |
| Sep 30, 2025 | -103,837.00 |
| Jun 30, 2025 | -139,072.00 |
| Jun 30, 2025 | -139,072.00 |
| Mar 31, 2025 | -187,222.00 |
| Mar 31, 2025 | -187,222.00 |
| Dec 31, 2024 | -186,390.00 |
| Dec 31, 2024 | -186,390.00 |
| Sep 30, 2024 | -246,932.00 |
| Sep 30, 2024 | -246,932.00 |
| Jun 30, 2024 | -144,795.00 |
| Jun 30, 2024 | -144,795.00 |
| Mar 31, 2024 | -163,819.00 |
| Mar 31, 2024 | -163,819.00 |
| Dec 31, 2023 | -290,025.00 |
| Dec 31, 2023 | -290,025.00 |